Lonza Group AG (LZAGY) Analyst/Investor Day Transcript

Lonza Group AG's analyst day provided updates on its COVID-19 vaccine and cell and gene therapy businesses.

The company expects strong growth in these areas in the coming years.

Lonza also provided guidance for 2027, with expectations for high single-digit growth in sales and core earnings per share.